Library

Welcome to our central library of project insights. Explore our consortium and partner introduction videos, along with our latest publications. Stay tuned as we continue to add technical publications, patient stories, and project milestones.

From CAR-T innovation to patient access

Exploring how CGT manufacturing can become more efficient and accessible - Pharma Horizons, September 2026.
View publication details
View publication online

Preparing CGT manufacturing for the next decade

Author: Kuhlen
Reducing CGT manufacturing complexity and shortening production timelines - Kuhlen et al., Spring 2026.
View publication details
Download PDF

Can Europe deliver the promise of advanced therapies?

Author: Steppan
Scaling advanced therapies for broader patient access - Steppan et al., August 2026.
View publication details
Download PDF

Overcoming Access Barriers in European CAR-T Therapy

How decentralized manufacturing can improve access to CAR-T therapy - Griebling et al., June 2026.
View publication details
Download PDF

Videos

European Society for Blood and Marrow Transplantation

European Society for Blood and Marrow Transplantation

EBMT adds clinical expertise and strong patient advocacy to advance patient-centred CAR-T therapy.
Watch Video
Fraunhofer-Institut für Experimentelles Software Engineering

Fraunhofer-Institut für Experimentelles Software Engineering

Fraunhofer IESE drives digital and AI solutions to enable safer, smarter point-of-care CAR-T.
Watch Video
Danmarks Tekniske Universitet

Danmarks Tekniske Universitet

DTU analyzes patient flow and care processes to optimize CAR-T treatments, efficiency and accessibility.
Watch Video
PRO-LIANCE GLOBAL SOLUTIONS

PRO-LIANCE GLOBAL SOLUTIONS

Pro-Liance provides regulatory expertise to develop safe and scalable CAR-T manufacturing at the hospital.
Watch Video
Helmholtz-Zentrum Dresden-Rossendorf

Helmholtz-Zentrum Dresden-Rossendorf

HZDR adds socio-economic and human-centered expertise to ensure CAR-T innovation meets real-world needs.
Watch Video
Charles River Laboratories Germany GmbH

Charles River Laboratories Germany GmbH

Charles River brings translational and preclinical expertise to accelerate next-generation CAR-T therapy.
Watch Video

Publications

From CAR-T innovation to patient access

From CAR-T innovation to patient access

Exploring how CGT manufacturing can become more efficient and accessible - Pharma Horizons, September 2026.
View publication details
Preparing CGT manufacturing for the next decade

Preparing CGT manufacturing for the next decade

Reducing CGT manufacturing complexity and shortening production timelines - Kuhlen et al., Spring 2026.
View publication details
Can Europe deliver the promise of advanced therapies?

Can Europe deliver the promise of advanced therapies?

Scaling advanced therapies for broader patient access - Steppan et al., August 2026.
View publication details
Overcoming Access Barriers in European CAR-T Therapy

Overcoming Access Barriers in European CAR-T Therapy

How decentralized manufacturing can improve access to CAR-T therapy - Griebling et al., June 2026.
View publication details
EY Biotech Report 2026

EY Biotech Report 2026

Germany’s opportunities to scale biotech innovation and global competitiveness – Zündorf et al., June 2026.
View publication details

Data insights

A caregiver’s perspective on access and waiting time

A caregiver’s perspective on access and waiting time

Caregivers face burdens from travel, uncertainty and coordination in CAR-T treatment journeys - May 7th, 2026
View the insights
CAR-T therapies: Life-saving, yet unequally accessible

CAR-T therapies: Life-saving, yet unequally accessible

Discover key insights on global CAR T access: reimbursement gaps, disparities and barriers – April 23rd, 2026
View the insights
What long CAR-T manufacturing times mean for patients

What long CAR-T manufacturing times mean for patients

See how improving CAR-T manufacturing could transform patient experiences. - April 10th, 2026
View the insights
On World Health Day, the focus is clear: Health for All.

On World Health Day, the focus is clear: Health for All.

Discover how closing the CAR-T access gap requires systems beyond science. - April 7th, 2026
View the insights
Why is CAR-T therapy access still limited for patients?

Why is CAR-T therapy access still limited for patients?

Early hospital-level insights from the EASYGEN consortium -  Febuary 19th, 2026
View the insights
Understanding who can access CAR-T therapy today

Understanding who can access CAR-T therapy today

Explore the data behind global CAR-T access, adoption, and patient barriers. Febuary 4th, 2026
View the insights

Sign up for updates

Our newsletter keeps you connected with the EASYGEN consortium — from scientific updates to collaborative opportunities and events.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Easygen logo
About EASYGENPartnersNewsLibraryContact us
Follow us:
Linkedin logo
ImpressumPrivacy Policy
AriseHealth logoOE logo2020INC logoThe Paak logoEphicient logoToogether logoToogether logo
This project has received funding from the Innovative Health Initiative Joint Undertaking (JU) under grant agreement No 101194710. The JU receives support from the European Union’s Horizon Europe research and innovation programme and EFPIA. — Funded by the European Union, the private members, and those contributing partners of the IHI JU. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the aforementioned parties. Neither of the aforementioned parties can be held responsible for them.